Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against Aldeyra Therapeutics, Inc.
MILWAUKEE , March 18, 2026 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against Aldeyra (Nasdaq: ALD). The investigation results from inaccurate statements Aldeyra...